Riskpilot← Back to searchSign inGet full accessKinmedi Oy
OYActiveY-tunnus 3344342-2Salkopallonkuja 7Retail sale of medical and orthopaedic goods · NACE 4774Est. 2023— employees
Revenue 2024
EUR 288K
EBITDA margin
166.5%
Equity ratio
90.6%
Financial strength
Net profit 2024
EUR 77K
| Revenue | EUR 288K | — |
| EBITDA | EUR 479K | — |
| Net profit | EUR 77K | — |
| Total assets | EUR 142K | — |
| Equity | EUR 129K | — |
| Employees | — | — |
Legal name
Kinmedi Oy
Y-tunnus number
3344342-2
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9. helmikuuta 2023
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmisteiden, luontaistuotteiden, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaankaupan tuotteiden vähittäiskauppa, tukkukauppa, valmistus, maahantuonti ja maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipalvelut, kosmetologin palvelut, konsultointi- ja koulutuspalvelut ja henkilöstönvuokraus. Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien, osakkeiden ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen.
Address
Salkopallonkuja 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 288 |
| Staff expenses | — |
| EBITDA | 479 |
| Depreciation & amort. | — |
| EBIT | 96 |
| Net financials | — |
| Profit before tax | 96 |
| Tax | 19 |
| Net profit | 77 |
| Item | 2024 |
|---|---|
| Total assets | 142 |
| Equity | 129 |
| Long-term debt | — |
| Short-term debt | 13 |
| Total debt | 13 |
EBITDA margin
166.5%
This company
15.8%
Market median
+954% vs market
20242024
Equity ratio
90.6%
This company
38.2%
Market median
+137% vs market
20242024
Return on equity
59.8%
This company
18.4%
Market median
+225% vs market
20242024
Net profit margin
26.8%
This company
8.1%
Market median
+231% vs market
20242024
Asset turnover
2.02×
This company
1.12×
Market median
+80% vs market
20242024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20242024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SJ Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
ES Deputy Member | Deputy Member | 2023 | — | — |
JB Audit | Audit | 2023 | — | — |
TT Deputy auditor | Deputy auditor | 2023 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kinmedi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Saija Johanna Kinnunen | Chief Executive Officer | 0 companies |
| Ella Sofia Kinnunen | Deputy Member | 0 companies |
| Jan-Erik Björklöf | Audit | 0 companies |
| Timo Tapio Post | Deputy auditor | 0 companies |